Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Pyxis Oncology Q2 EPS $(0.29) Misses $(0.28) Estimate

Author: Benzinga Newsdesk | August 14, 2024 04:33pm
Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.28) by 3.57 percent. This is a 29.27 percent increase over losses of $(0.41) per share from the same period last year.

Posted In: PYXS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist